Segarra, A

Efficacy and safety of bortezomib in refractory lupus nephritis: a single-center experience. [electronic resource] - Lupus Feb 2020 - 118-125 p. digital

Publication Type: Journal Article

1477-0962

10.1177/0961203319896018 doi


Adult
Antineoplastic Agents--therapeutic use
Bortezomib--adverse effects
Cyclophosphamide--therapeutic use
Drug Therapy, Combination
Female
Glucocorticoids--therapeutic use
Humans
Immunosuppressive Agents--therapeutic use
Lupus Nephritis--drug therapy
Proteinuria--drug therapy
Remission Induction
Retrospective Studies
Rituximab--therapeutic use
Young Adult